0001214659-21-012213.txt : 20211123 0001214659-21-012213.hdr.sgml : 20211123 20211123194705 ACCESSION NUMBER: 0001214659-21-012213 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211122 FILED AS OF DATE: 20211123 DATE AS OF CHANGE: 20211123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AULT MILTON C III CENTRAL INDEX KEY: 0001212502 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40483 FILM NUMBER: 211440660 MAIL ADDRESS: STREET 1: 15641 RED HILL AVENUE, SUITE 200 CITY: TUSTIN STATE: CA ZIP: 92780 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alzamend Neuro, Inc. CENTRAL INDEX KEY: 0001677077 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811822909 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 BUSINESS PHONE: 844-722-6333 MAIL ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 4 1 marketforms-54396.xml PRIMARY DOCUMENT X0306 4 2021-11-22 0001677077 Alzamend Neuro, Inc. ALZN 0001212502 AULT MILTON C III 3802 SPECTRUM BOULEVARD, SUITE 112C TAMPA FL 33612 false false true false Common Stock 2021-11-22 4 P false 15000 1.8999 A 6880388 I By Digital Power Lending, LLC Common Stock 2021-11-23 4 P false 4681 1.99 A 6885069 I By Digital Power Lending, LLC Common Stock 250000 D Common Stock 15000000 I By Ault Life Sciences, Inc. Common Stock 10000000 I By Ault Life Sciences Fund, LLC The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.8999. The range of purchase prices on the transaction date was $1.89 to $1.90 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC. /s/ Milton C. Ault, III 2021-11-23